NEWS

Today, during a conference held at Fondazione Prada in Milan, the Prada Group has announced its partnership with the Gianni Bonadonna Foundation, a therapeutic and scientific research project in the field of oncology.

The purpose of this program is to give continuity to the work of Gianni Bonadonna, a true medicine giant who has innovated every aspect of research and therapies, allowing to reach enormous progress and concrete clinical successes in the treatment of neoplasia.

In the presence of Miuccia Prada - Co-CEO of the Prada Group and President of the Prada Foundation - and of a large representation of media and members of the scientific community, during the morning there were speeches of: Astrid Welter - Head of Programs Fondazione Prada, Carlo Mazzi - Chairman of the Prada Group, Luca Gianni - President of the Gianni Bonadonna Foundation and of Larry Norton, Senior Vice President of the Memorial Sloan Kettering Cancer Center in New York.

The afternoon welcomed over 150 Italian and international oncologists for the scientific symposium entitled: "Envisioning the Future of Cancer Treatment Innovation".